Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Equivalence Between GSK2340272A and GSK2340274A Influenza Vaccines in Adults Aged 18 to 60 Years

NCT00979407 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00979407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00979407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Equivalence Between GSK2340272A and GSK2340274A Influenza Vaccines in Adults Aged 18 to 60 Years
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 12, 2009
Completion date
November 4, 2010
Enrollment
336 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza